|Usage:||Professional Use||Shelf Life:||24 Months|
K2 Rapid Test Cassette,
Synthetic Cannabinoid Rapid Test Cassette,
DOA Rapid Test Kit
CE FDA Synthetic Cannabinoid (K2) Rapid Test Cassette DOA Rapid Test Kit for Urine Sample
Synthetic Cannabinoid (K2) Ra[id Test is a rapid, screening test for the qualitative detection of Synthetic Cannabinoid (K2) and metabolites in human urine at specified cut oflevels.
For professional use only.
For in vitro diagnostic use only.
Synthetic Cannabinoid (K2) Rapid Test is an immuno-chromatographic assay for the qualitative determination of the presence of Synthetic Cannabinoid (K2) listed in the table below.
|Synthetic Cannabinoid (K2)||JWH-018 PantanoicAcid||50 ng/mL|
This assay provides only a preliminary analytical test result. Gas Chromatography/Mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied toSynthetic Cannabinoid (K2) of abuse test result, particularly when preliminary positive results are indicated.
Since 2004, herbal mixtures such as ‘Spice’ are sold in Switzerland, Austria, Germany and other European countries mainly via Internet shops. Although declared as incense, they are smoked as ‘bio-drugs’ by the consumers. In corresponding blogs, drug users reported cannabis-like effects after smoking. These products enjoy great popularity particularly among younger people, as up to now the mixtures are sold in head shops and via internet in many countries without age restriction. JWH-018 was developed and evaluated in basic scientific research to study structure activity relationships related to the cannabinoid receptors. JWH073 has been identified in numerous herbal products, such as “Spice”, “K2”, K3” and others. These products may be smoked for their psychoactive effect.
Synthetic Cannabinoid (K2) Rapid Test is a competitive immunoassay that is used to screen for the presence of Synthetic Cannabinoid (K2) and metabolites in urine. It is chromatographic absorbent device in which, drugs within a urine sample, competitively combined to a limited number of drug monoclonal antibody (mouse) conjugate binding sites.
When the test is activated, the urine is absorbed into test by capillary action, mixes with the respective drug monoclonal antibody conjugate, and flows across a pre-coated membrane. When drug within the urine sample is below the detection level of the test, respective drug monoclonal antibody conjugate binds to the respective drug-protein conjugate immobilized in the Test Region (T) of the test . This produces a colored Test line in the Test Region (T) of the Test, which, regardless of its intensity, indicates a negative test result.
When sample drug levels are at or above the detection level of the test, the free drug in the sample binds to the respective drug monoclonal antibody conjugate, preventing the respective drug monoclonal antibody conjugate from binding to the respective drug-protein conjugate immobilized in the Test Region (T) of the device. This prevents the development of a distinct colored band in the test region, indicating a preliminary positive result.
To serve as a procedure control, a colored line will appear at the Control Region (C) of Test, if the test has been performed properly.
【WARNINGS AND PRECAUTIONS】
【STORAGE AND STABILITY】
Test must be in room temperature ( 15ºC to 30ºC)
【INTERPRETATION OF RESULTS】
Preliminary positive (+)
Only one colored band appears, in the control region (C). No colored band appears in the test region (T).
Two colored bands appear on the membrane. One band appears in the control region (C) and another band appears in the test region (T).
Control band fails to appear. Results from any test which has not produced a control band at the specified read time must be discarded. Please review the procedure and repeat with a new test. If the problem persists, discontinue using the kit immediately and contact your local distributor.